|
Get Full Access To This Report | or | Upgrade to PrivCo Premium |
| $99 Single Company Access | Instant Full Site-Wide Access Currently 50% Off Until May. 31! |
NeuroNova AB
NeuroNova AB has been acquired by a public company.
PrivCo has ceased its coverage of NeuroNova AB and below is the archived report.
Business Summary
NeuroNova AB, a biopharmaceutical company, engages in the development and commercialization of therapies for the treatment of central nervous system disorders. It was acquired by Newron Pharmaceuticals, a public company, in June 2012.
Overview & Corporate Organization
Basic Information
| Fiscal Year End: | 12/31 |
| City: | Stockholm |
| Country: | Sweden |
| Website: | www.neuronova.com |
Industry Information
PrivCo Industries (Sector > Industry > Sub-Industry)
| Healthcare > Pharmaceuticals |
| Technology > Biotechnology |
The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.
Mergers & Acquisitions
| Date | Status | Target | Buyer | Deal Type | Price | |
| Details | Jun. 2012 | Completed | View1 | View | Acquisition Direct Share Purchase | View |
| 1 | Investor AB and HealthCap, holders...Read More → |
Full-length notes are available with Single Report Access or PrivCo Premium Subscription. |
Missing a deal? Tell us about it! tips@privco.com
Supplemental Resources
|
Get Full Access To This Report | or | Upgrade to PrivCo Premium |
| $99 Single Company Access | Instant Full Site-Wide Access Currently 50% Off Until May. 31! |




